Matches in Nanopublications for { ?s ?p "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_assertion description "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239521.RAllhwN8LQeiPvgaOe2k-d6hjrlvBKzmX-0yfO9KvJMB4130_provenance.
- NP1027202.RAKS-UjPUTzSIyqGE88X1w0nL3dx0NNt7KS_HqRR4LGgM130_assertion description "[Circulating ANXA2 in HCC patients was significantly higher than that of other liver diseases (P < 0.01) except metastatic liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1027202.RAKS-UjPUTzSIyqGE88X1w0nL3dx0NNt7KS_HqRR4LGgM130_provenance.